P110 Lenalidomide in low and int-1 risk MDS with del5q: efficacy and quality of life

E. Oliva, R. Latagliata, M. Breccia, F. Morabito, R. Ghio, A. Poloni, C. Barate, A. Cortelezzi, A. Ricco, C. Alati, M. Aloe Spiriti, F. Nobile

Research output: Contribution to journalArticle

Original languageEnglish
JournalLeukemia Research
Volume33
Issue numberSUPPL. 1
DOIs
Publication statusPublished - May 2009

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Oliva, E., Latagliata, R., Breccia, M., Morabito, F., Ghio, R., Poloni, A., Barate, C., Cortelezzi, A., Ricco, A., Alati, C., Aloe Spiriti, M., & Nobile, F. (2009). P110 Lenalidomide in low and int-1 risk MDS with del5q: efficacy and quality of life. Leukemia Research, 33(SUPPL. 1). https://doi.org/10.1016/S0145-2126(09)70191-2